Below are the earnings highlights for Outlook Therapeutics, Inc. (OTLK):
Earnings: $17.3 million in Q1 vs. -$11.1 million in the same period last year.
EPS: $0.72 in Q1 vs. -$0.86 in the same period last year.
Excluding items, Outlook Therapeutics, Inc. reported adjusted earnings of -$21.5 million or -$0.89 per share for the period.
For comments and feedback: editorial@rttnews.com